Code Snippets
curl "https://financialdata.net/api/v1/analyst-consensus?identifier=DHR&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/analyst-consensus?identifier=DHR&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/analyst-consensus?identifier=DHR&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "DHR",
"central_index_key": "0000313616",
"registrant_name": "DANAHER CORP /DE/",
"average_price_target": 235.31,
"highest_price_target": 255.0,
"lowest_price_target": 200.0,
"buy_recommendations": 16,
"sell_recommendations": 0,
"hold_recommendations": 1
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security. (e.g., MSFT) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
Analyst consensus represents the collective price targets and ratings from professional equity research analysts covering a publicly traded company. Aggregating the estimates gives a view of overall sentiment rather than relying on a single opinion. The API endpoint returns consensus metrics, including 12-month forward price targets as well as buy, hold, and sell recommendation counts.
Company Profile
DANAHER CORP /DE/
NYSE: DHR- Market Cap:$125.90B
- ISIN:US2358511028
- Fiscal Year End:12/31
- CEO:Rainer Blair
- Employees:63000
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.